Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 14%
Buy 23%
Hold 46%
Sell 9%
Strong Sell 9%

Bulls say

CME Group has demonstrated strong financial performance, highlighted by a quarterly dividend increase of approximately 9% year-over-year, reflecting robust free cash flow generation. The company's trading activities, particularly in Henry Hub Natural Gas and equity index products, have also seen significant year-over-year growth, with a 33% increase in daily average volume (ADV) for Natural Gas futures and an 11% rise for Micro E-mini Nasdaq 100 futures. Furthermore, innovative product offerings and a strategic focus on customer demand have resulted in substantial revenue growth, with a total of approximately 2.8 million ADV generated over the past five years, positively influencing the company's outlook.

Bears say

CME Group is facing significant pressures in the agricultural commodities sector, particularly with declines in soybean and cattle markets influenced by favorable weather conditions and reduced supply concerns, which could negatively impact overall market sentiment and financial conditions. The company's downside scenario projects a ~10% decrease in FY26E EPS, highlighting the potential risks tied to open interest declines and their implications for share performance. Additionally, while market data and information services revenue slightly exceeded estimates, the overall trend of soft volumes in QTD raises concerns about sustained growth and profitability in a challenging market environment.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 23% recommend Buy, 46% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Aug 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $213.46, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $213.46, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.